vs
NATIONAL HEALTH INVESTORS INC（NHI）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是NATIONAL HEALTH INVESTORS INC的1.9倍（$197.9M vs $105.8M），NATIONAL HEALTH INVESTORS INC净利率更高（36.1% vs 6.7%，领先29.3%），NATIONAL HEALTH INVESTORS INC同比增速更快（23.4% vs 13.6%），REPLIGEN CORP自由现金流更多（$17.6M vs $-57.5M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 13.9%）
Oscar Health是美国营利性健康保险公司，2012年由约书亚·库什纳、凯文·纳泽米和马里奥·施洛瑟创立，总部位于纽约市。公司深耕健康保险领域，通过远程医疗、医疗专用技术界面及透明的理赔定价体系，降低患者的服务使用难度。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
NHI vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.9倍
$105.8M
营收增速更快
NHI
高出9.8%
13.6%
净利率更高
NHI
高出29.3%
6.7%
自由现金流更多
RGEN
多$75.0M
$-57.5M
两年增速更快
RGEN
近两年复合增速
13.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $105.8M | $197.9M |
| 净利润 | $38.2M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 36.1% | 6.7% |
| 营收同比 | 23.4% | 13.6% |
| 净利润同比 | -11.7% | 143.9% |
| 每股收益（稀释后） | $0.80 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NHIRGEN
| Q4 25 | $105.8M | $197.9M | ||
| Q3 25 | $89.8M | $188.8M | ||
| Q2 25 | $90.7M | $182.4M | ||
| Q1 25 | $89.3M | $169.2M | ||
| Q4 24 | $85.8M | $174.1M | ||
| Q3 24 | $82.9M | $154.9M | ||
| Q2 24 | $85.0M | $154.1M | ||
| Q1 24 | $81.5M | $151.3M |
净利润NHIRGEN
| Q4 25 | $38.2M | $13.3M | ||
| Q3 25 | $32.9M | $14.9M | ||
| Q2 25 | $37.0M | $14.9M | ||
| Q1 25 | $34.2M | $5.8M | ||
| Q4 24 | $43.2M | $-30.3M | ||
| Q3 24 | $28.5M | $-654.0K | ||
| Q2 24 | $35.3M | $3.3M | ||
| Q1 24 | $30.9M | $2.1M |
毛利率NHIRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率NHIRGEN
| Q4 25 | — | 9.0% | ||
| Q3 25 | — | 8.9% | ||
| Q2 25 | — | 7.6% | ||
| Q1 25 | — | 3.9% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | — | -5.1% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | — | 1.3% |
净利率NHIRGEN
| Q4 25 | 36.1% | 6.7% | ||
| Q3 25 | 36.6% | 7.9% | ||
| Q2 25 | 40.8% | 8.2% | ||
| Q1 25 | 38.3% | 3.4% | ||
| Q4 24 | 50.4% | -17.4% | ||
| Q3 24 | 34.4% | -0.4% | ||
| Q2 24 | 41.5% | 2.2% | ||
| Q1 24 | 38.0% | 1.4% |
每股收益（稀释后）NHIRGEN
| Q4 25 | $0.80 | $0.24 | ||
| Q3 25 | $0.69 | $0.26 | ||
| Q2 25 | $0.79 | $0.26 | ||
| Q1 25 | $0.74 | $0.10 | ||
| Q4 24 | $0.96 | $-0.55 | ||
| Q3 24 | $0.65 | $-0.01 | ||
| Q2 24 | $0.81 | $0.06 | ||
| Q1 24 | $0.71 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $19.6M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $1.5B | $2.1B |
| 总资产 | $2.8B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资NHIRGEN
| Q4 25 | $19.6M | $767.6M | ||
| Q3 25 | $81.6M | $748.7M | ||
| Q2 25 | $18.6M | $708.9M | ||
| Q1 25 | $135.0M | $697.2M | ||
| Q4 24 | $24.3M | $757.4M | ||
| Q3 24 | $15.6M | $784.0M | ||
| Q2 24 | $14.8M | $809.1M | ||
| Q1 24 | $11.4M | $780.6M |
总债务NHIRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益NHIRGEN
| Q4 25 | $1.5B | $2.1B | ||
| Q3 25 | $1.5B | $2.1B | ||
| Q2 25 | $1.5B | $2.1B | ||
| Q1 25 | $1.4B | $2.0B | ||
| Q4 24 | $1.4B | $2.0B | ||
| Q3 24 | $1.2B | $2.0B | ||
| Q2 24 | $1.2B | $2.0B | ||
| Q1 24 | $1.2B | $2.0B |
总资产NHIRGEN
| Q4 25 | $2.8B | $2.9B | ||
| Q3 25 | $2.7B | $2.9B | ||
| Q2 25 | $2.7B | $2.9B | ||
| Q1 25 | $2.8B | $2.9B | ||
| Q4 24 | $2.6B | $2.8B | ||
| Q3 24 | $2.5B | $2.8B | ||
| Q2 24 | $2.5B | $2.9B | ||
| Q1 24 | $2.5B | $2.8B |
负债/权益比NHIRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $236.6M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-57.5M | $17.6M |
| 自由现金流率自由现金流/营收 | -54.3% | 8.9% |
| 资本支出强度资本支出/营收 | 277.9% | 4.1% |
| 现金转化率经营现金流/净利润 | 6.20× | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流NHIRGEN
| Q4 25 | $236.6M | $25.7M | ||
| Q3 25 | $62.5M | $48.1M | ||
| Q2 25 | $59.8M | $28.6M | ||
| Q1 25 | $46.5M | $15.0M | ||
| Q4 24 | $207.8M | $39.2M | ||
| Q3 24 | $48.6M | $49.3M | ||
| Q2 24 | $60.7M | $42.2M | ||
| Q1 24 | $40.8M | $44.7M |
自由现金流NHIRGEN
| Q4 25 | $-57.5M | $17.6M | ||
| Q3 25 | $-88.2M | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | $49.8M | $33.6M | ||
| Q3 24 | $1.5M | $42.3M | ||
| Q2 24 | — | $37.4M | ||
| Q1 24 | — | $36.4M |
自由现金流率NHIRGEN
| Q4 25 | -54.3% | 8.9% | ||
| Q3 25 | -98.2% | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | 58.1% | 19.3% | ||
| Q3 24 | 1.9% | 27.3% | ||
| Q2 24 | — | 24.3% | ||
| Q1 24 | — | 24.0% |
资本支出强度NHIRGEN
| Q4 25 | 277.9% | 4.1% | ||
| Q3 25 | 167.8% | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | 184.2% | 3.2% | ||
| Q3 24 | 56.8% | 4.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 5.5% |
现金转化率NHIRGEN
| Q4 25 | 6.20× | 1.93× | ||
| Q3 25 | 1.90× | 3.23× | ||
| Q2 25 | 1.62× | 1.92× | ||
| Q1 25 | 1.36× | 2.57× | ||
| Q4 24 | 4.80× | — | ||
| Q3 24 | 1.70× | — | ||
| Q2 24 | 1.72× | 12.70× | ||
| Q1 24 | 1.32× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
